Skip to main content
. 2018 Mar 16;17:54. doi: 10.1186/s12944-018-0703-y

Table 5.

Association between total phytosterols intake and prevalence of abdominal obesity

Overall Q1 Q2 Q3 Q4
 Participants, n 228 228 228 228
 No. of cases, n 77 62 59 54
 Intake, mg/d 161.9 231.3 294 383
 Crude 1 0.732 (0.491, 1.093) 0.685 (0.457, 1.025) 0.609 (0.404, 0.918)*
 Model 1 1 0.806 (0.513, 1.266) 0.566 (0.360, 0.891)* 0.490 (0.305, 0.785)**
 Model 2 1 0.512 (0.302, 0.868)* 0.423 (0.259, 0.691)** 0.239 (0.127, 0.450)**
Men Q1 Q2 Q3 Q4
 Participants, n 102 102 102 103
 No. of cases, n 51 43 36 36
 Intake, mg/d 157.3 233 381.4 301
 Crude 1 0.741 (0.426, 1.289) 0.529 (0.302, 0.927)* 0.545 (0.311, 0.957)*
 Model 1 1 0.657 (0.355, 1.215) 0.520 (0.303, 0.955)* 0.510 (0.293, 0.951)*
 Model 2 1 0.462 (0.233, 0.918)* 0.407 (0.191, 0.864)* 0.344 (0.144, 0.819)*
Women Q1 Q2 Q3 Q4
 Participants, n 125 126 126 126
 No. of cases, n 25 23 20 18
 Intake, mg/d 165.6 229.3 287.6 384.2
 Crude 1 0.893 (0.476, 1.676) 0.755 (0.395, 1.443) 0.667 (0.343, 1.295)
 Model 1 1 0.738 (0.354, 1.539) 0.672 (0.305, 1.480) 0.341 (0.151, 0.770)*
 Model 2 1 0.525 (0.216, 1.276) 0.497 (0.221, 1.118) 0.321 (0.140, 0.571)**

Model 1: adjusting for age, education, income, PAL, exercise status, smoking and drinking habits

Model 2: Model 1 + dietary carbohydrate, fat, protein, fiber and cholesterol intake were adjusted

* P < 0.05; ** P < 0.01 compared with the 1st quartile